vimarsana.com
Home
Live Updates
FDA Approves RAS Mutation Detection Kit as Companion Diagnos
FDA Approves RAS Mutation Detection Kit as Companion Diagnos
FDA Approves RAS Mutation Detection Kit as Companion Diagnostic for Panitumumab in mCRC
The FDA has approved the CRCdx RAS Mutation Detection Kit as a companion diagnostic for panitumumab in the treatment of patients with metastatic colorectal cancer (mCRC), according to an announcement from EntroGen.
Related Keywords
Matthew Minkovsky ,
Amgen ,
Detection Kit ,
Dmcrc ,
Fda ,
Colorectal ,